Effects of dietary selenium yeast supplementation on the production performance, egg quality, antioxidant and plasma biochemical parameters of laying hens Authors: Tingting Wang, Shengchang Chen, Shengyong Lu, Haixia Li, Mengmeng Ni, Jun Hao, Wei Cheng, Jingshang Li, Yunce Cai, Jiaxiu An, Long Qin Published: 2025 ABSTRACT AbstractThis study was designed to evaluate the effects of dietary selenium yeast (SY) supplementation (0.3–0.9 mg/kg Se) on key production performance parameters, egg quality traits, antioxidant capacity, and plasma immune indices in laying hens, with concurrent verification of the safety profile of the upper test dose. A total of 108 healthy Hy-Line Brown laying hens (162 days old, weighing 1.61 ± 0.05 kg) were randomly allocated to four treatment groups, each comprising three replicates of nine birds. Following a 10-day acclimatisation period, a 60-day feeding trial was conducted. Dietary SY had no significant impact on core production metrics (all P > 0.05) but improved egg quality in a time and dose-dependent manner under the present experimental conditions: eggshell thickness, albumen height, and Haugh units were elevated in linear/quadratic patterns (P < 0.05), with the most pronounced effects observed in the 0.9SY treatment. SY supplementation increased the selenium content in eggs (0.32–0.977 mg/kg) and plasma (0.15–0.42 mg/L) of laying hens in a dose-dependent manner (linear trends, P < 0.05), with all SY groups meeting the Chinese standard for selenium-enriched eggs (GH/T1135-2017; ≥0.15 mg/kg). Antioxidant capacity was enhanced in a tissue-specific manner: hepatic activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), alongside plasma total antioxidant capacity (T-AOC), were elevated linearly and/or quadratically (P < 0.05), while yolk malondialdehyde (MDA) concentrations were reduced by Day 60 (linear/quadratic P < 0.05). SY exerted selective immunomodulatory effects: plasma concentrations of interleukin-6 (IL-6) and immunoglobulin M (IgM) decreased in linear and/or quadratic trends (P < 0.05), immunoglobulin G (IgG) tended to increase linearly (0.05 < P < 0.10), and immunoglobulin A (IgA) remained unaltered (P > 0.05). Critically, the 0.9 mg/kg Se dose—exhibiting the most favourable outcomes across all measured endpoints—remained within the dietary Se safety threshold (≤ 1.0 mg/kg) established by the National Research Council (NRC, 1994), in the absence of overt toxicological manifestations. In conclusion, under the parameters of this 60-day trial, dietary SY supplementation safely enhances egg quality, antioxidant defence, and immune homeostasis in laying hens, with 0.9 mg/kg Se emerging as the optimal dose. These findings support the potential utility of SY as a functional feed additive for selenium-enriched egg production in analogous commercial production systems.Keywords: Antioxidant capacity, Egg quality, Immune ability, Laying hens, Selenium yeastSubject terms: Animal physiology, Animal behaviour Introduction Selenium (Se), an essential trace element for animals and humans1, has been extensively studied since the 1990s, when selenium yeast (SY) emerged as a promising feed additive2. Se can be obtained from both food sources and dietary supplements. Compared with inorganic forms, this organic Se source has superior bioavailability, reduced toxicity3, and enhanced antioxidant and immunoregulatory effects in animals4. These advantages have driven substantial research interest in SY applications. The physiological role of Se, supplementation strategies, and the impacts of Se supplementation on production performance and egg quality have become hot topics in poultry research5. This element serves as a critical cofactor for glutathione peroxidase (GSH-Px), a key enzyme in free radical scavenging and oxidative stress mitigation6,7. Notably, both sodium selenite (SS) and selenium-enriched yeast (SeY) supplementation increase glutathione peroxidase 4 (GPx4) levels, thereby directly modulating GSH-Px activity8. In addition to its antioxidant functions, Se modulates immune cell activation, enhances disease resistance, and increases growth and egg production while reducing morbidity9. Previous studies have demonstrated that Se regulates blood immunological parameters in poultry10, particularly through immunoglobulin upregulation and production inhibition11. Additionally, Se is involved in fundamental biological processes, including DNA synthesis, thyroid hormone metabolism, and reproductive processes12. Studies on dietary supplementation revealed elevated Se deposition in hepatic and yolk tissues of laying hens fed Se-supplemented diets compared with control hens, with SY supplementation significantly improving eggshell strength and increasing Haugh units13. Laying hens fed SY exhibit higher egg mass output, lower oxidative stress, and better overall health14. Overall, Se regulates animal productivity through multiple mechanisms, including beneficial modulation of immune homeostasis, antioxidant activity, thyroid regulation, and nucleic acid metabolism. However, relevant data on appropriate dietary SY levels for laying hens under semiopen systems—targeting concurrent antioxidant and immune support, as well as Se enrichment safety—remain limited. Few prior studies provide direct reference for such practical production scenarios, where hens face moderate environmental variability. This investigation aimed to systematically evaluate the effects of SY supplementation on production performance, egg quality, Se deposition, antioxidant capacity, and plasma immunological parameters. The findings provide basic reference for the rational use of SY in similar poultry production systems and the development of selenium-enriched egg products. Results Production performance and egg quality parameters Dietary SY supplementation had no significant (P > 0.05) influence on laying hen performance metrics (Table 1), including average daily feed intake, average egg weight, feed-to-egg ratio, laying rate, and laying hen weight gain (all ANOVA P > 0.05; no dose–response trends). Table 1Effects of different concentrations of selenium yeast in the diet on the performance of laying hens.Parameter 1)0SY0.3SY0.6SY0.9SYSEMP value2)ALQADFI/[g/(d-egg)]119.134119.816118.165116.4312.3250.7570.3750.618AEW/g56.18056.02055.54057.4500.5250.1420.1930.084F/E2.8102.8502.8772.8870.2210.9950.8010.947Laying rate/%0.7770.7690.7560.7190.0560.8880.4800.798Laying hens to put on weight/g0.3260.3810.3560.3180.0320.5120.7400.1811) In the table, values with different superscripts indicate a significant difference (P < 0.05). ADFI, average daily feed intake. AEW, average egg weight. F/E, feed/egg ratio. SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment.2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Effects of different concentrations of selenium yeast in the diet on the performance of laying hens. ADFI /[g/(d-egg)] 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). ADFI, average daily feed intake. AEW, average egg weight. F/E, feed/egg ratio. SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. 2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Analysis of egg quality characteristics (Table 2) revealed no significant effects on egg shape index and yolk colour at both the 30-day and 60-day sampling intervals (all ANOVA P > 0.05), with other parameters exhibiting time-dependent dose responses: Eggshell thickness increased linearly with SY dose by Day 60 (ANOVA P < 0.05; linear P < 0.05), with the 0.9SY treatment showing a thicker shell than the control, while this parameter remained unchanged on Day 30 (ANOVA P > 0.05). In contrast, eggshell strength linearly decreased on Day 30 (ANOVA P < 0.01; linear P < 0.01), with the 0.9SY treatment displaying lower strength than the control, and no significant effect was noted (ANOVA P > 0.05) at 60 d. Both egg weight and albumen height linearly increased with SY supplementation on Day 30 (ANOVA P < 0.05; linear P < 0.01), with the 0.9SY treatment exhibiting the highest values, while no significant effects were detected at 60 days (ANOVA P > 0.05). Haugh units showed distinct temporal patterns: a linear increase on Day 30 (ANOVA P < 0.05; linear P < 0.05; 0.9SY > 0SY) and a quadratic tendency towards increase on Day 60 (ANOVA P = 0.052; quadratic P < 0.05), with the 0.9SY treatment showing the highest value. Collectively, these outcomes suggest SY supplementation may optimise egg freshness and structural quality, with maximal efficacy achieved with the 0.9SY treatment. Table 2Effects of different concentrations of selenium yeast in the diet on the egg quality of laying hens.ParameterTime point0SY 1)0.3SY0.6SY0.9SYSEMP value2)ALQEgg shape index30 d1.2771.2831.2981.3040.0180.6670.2230.98160 d1.3101.2761.2761.3210.0160.4860.7170.053Eggshell thickness/mm30 d0.3080.3150.3030.2970.0060.8780.0240.17760 d0.308b0.343ab0.354a0.362a0.0100.007 < 0.0010.213Eggshell strength/N30 d29.809a28.028ab25.240 bc24.063c0.829 < 0.001 < 0.0010.71860 d44.68342.42843.76443.1230.6790.1290.2760.241Egg weight/g30 d54.353b55.207ab55.333ab57.139a0.6480.0300.0050.46660 d58.82359.10357.58259.6961.0140.5160.8100.371Albumen height/mm30 d5.485b5.690b5.873b6.872a0.200 < 0.001 < 0.0010.05360 d6.8456.9796.9197.0310.2390.9530.6440.963Yolk colour30 d10.58210.81910.8179.8020.1510.1260.001 < 0.00160 d12.09811.57511.67311.6690.1400.1400.0640.070Haugh unit30 d74.003b74.832b77.324b82.882a1.429 < 0.001 < 0.0010.10560 d81.533ab80.692ab74.444b83.112a2.2650.0500.8820.0421) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment.2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Effects of different concentrations of selenium yeast in the diet on the egg quality of laying hens. 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. 2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Selenium enrichment profiles Egg and plasma Se concentrations, as well as per-egg Se deposition, all exhibited linear dose-dependent increases with dietary SY (Table 3; ANOVA P < 0.05; linear P < 0.05). Egg Se content peaked in the 0.9SY treatment (0.977 mg/kg), while plasma Se levels also reached the highest in this group. Notably, egg Se contents in all SY-supplemented groups (0.3SY–0.9SY) met the Chinese national standard for selenium-enriched eggs (GH/T1135-2017; 0.15–0.50 mg/kg). Overall, dietary SY supplementation dose-dependently enhances Se deposition in eggs and plasma, with the 0.9SY treatment demonstrating maximal efficacy. Table 3Effects of dietary supplementation with different levels of selenium yeast on egg and plasma selenium contents.Parameter 1)0SY0.3SY0.6SY0.9SYSEMP Value2)ALQEgg (mg/kg)0.221d0.512c0.723b0.977a0.030 < 0.001 < 0.0010.549Plasma (mg/L)0.057b0.087 ab0.110 ab0.160a0.0200.0320.0050.626Se content in one egg (ug/egg) 3)13.161d30.078c41.741b58.682a2.081 < 0.001 < 0.0010.9951) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment.2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis.3) The Se content of each egg was calculated.[Formula: Se content of an egg (µg/egg) = Se content of an egg (mg/kg) × 1000 × Egg weight (g)/1000]. Effects of dietary supplementation with different levels of selenium yeast on egg and plasma selenium contents. 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. 2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. 3) The Se content of each egg was calculated. [Formula: Se content of an egg (µg/egg) = Se content of an egg (mg/kg) × 1000 × Egg weight (g)/1000]. Antioxidant parameters in the liver Core hepatic antioxidant indices exhibited distinct dose responses to SY supplementation (Table 4): Hepatic malondialdehyde (MDA) content remained unaffected (ANOVA P > 0.05), while total antioxidant capacity (T-AOC) displayed dose-responsive modulation (ANOVA P < 0.05), with the 0.3SY treatment showing higher capacity than the 0.6SY treatment. Both superoxide dismutase (SOD) and GSH-Px activities showed linear and quadratic increases with SY dose (ANOVA P < 0.05 for both; linear/quadratic P < 0.05 for both), with the 0.9SY treatment exhibiting the highest activities. These results indicate Se supplementation improves the hepatic antioxidant capacity of laying hens, with the 0.9SY treatment being the most effective. Table 4Effects of dietary selenium yeast supplementation at different concentrations on liver antioxidant parameters.Parameter 1)0SY0.3SY0.6SY0.9SYSEMP value2)ALQT-AOC (μmol/mg prot)0.138ab0.169a0.135b0.142ab0.0090.0380.5870.178MDA (nmol/mg prot)0.5210.5520.6510.5720.0370.1060.1400.150SOD (U/mg prot)597.169a514.106b616.798a647.796a16.560 < 0.0010.0020.002GSH-Px (U/mg prot)8.290b7.430c8.619ab8.887a0.126 < 0.001 < 0.001 < 0.0011) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. T-AOC, total antioxidant capacity. MDA, Malondialdehyde. SOD, superoxide dismutase. GSH-Px, glutathione peroxidase.2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Effects of dietary selenium yeast supplementation at different concentrations on liver antioxidant parameters. 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. T-AOC, total antioxidant capacity. MDA, Malondialdehyde. SOD, superoxide dismutase. GSH-Px, glutathione peroxidase. 2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Plasma antioxidant parameters Plasma MDA concentrations remained unaffected by dietary interventions (Table 5; ANOVA P > 0.05). Plasma T-AOC exhibited linear and quadratic increases with SY dose (ANOVA P < 0.05; linear/quadratic P < 0.05 for both), with the 0.3SY–0.9SY treatment groups showing higher capacity than the 0SY. Both plasma SOD and GSH-Px activities linearly increased with SY supplementation (ANOVA P < 0.05 for both; linear P < 0.05 for both), with the 0.9SY treatment exhibiting the highest activities. These findings indicate Se supplements enhance plasma antioxidant capacity in laying hens, with 0.9SY treatment being the most effective. Table 5Effects of dietary selenium yeast supplementation at different concentrations on plasma antioxidant parameters.Parameter 1)0SY0.3SY0.6SY0.9SYSEMP value2)ALQT-AOC (μmol/mg prot)5.250b8.129a8.890a8.963a0.6380.032 < 0.0010.035MDA (nmol/mg prot)6.3436.4525.5905.3060.6320.6040.1700.758SOD (U/mg prot)518.789c689.526b766.334b927.412a41.5590.005 < 0.0010.908GSH-Px (U/mg prot)2358.426c2722.581 bc3182.794ab3225.807a123.0550.040 < 0.0010.2011) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. T-AOC, total antioxidant capacity. MDA, Malondialdehyde. SOD, superoxide dismutase. GSH-Px, glutathione peroxidase.2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Effects of dietary selenium yeast supplementation at different concentrations on plasma antioxidant parameters. 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. T-AOC, total antioxidant capacity. MDA, Malondialdehyde. SOD, superoxide dismutase. GSH-Px, glutathione peroxidase. 2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Yolk antioxidant parameters Yolk antioxidant status exhibited time-dependent dose responses (Table 6): Neither T-AOC nor SOD activity was affected by treatment at either sampling interval (ANOVA P > 0.05), though hens fed the 0.9SY diet consistently presented the highest enzymatic activity. Yolk MDA levels remained stable on Day 30 (ANOVA P > 0.05) but displayed linear and quadratic decreases with SY dose on Day 60 (ANOVA P < 0.05; linear/quadratic P < 0.05 for both), with the 0.9SY treatment showing lower MDA levels than the control. These results indicate SY supplementation exerts a time-dependent effect on yolk antioxidant status, with a more significant reduction in MDA observed in the later phase of the experiment. Table 6Effects of dietary selenium yeast supplementation at different concentrations on egg yolk antioxidant parameters.Parameter1)Times0SY0.3SY0.6SY0.9SYSEMP value2)ALQT-AOC (μmol/mg prot)30 d0.0770.0700.0880.1260.0200.2760.0850.35960 d0.0620.0720.0730.0750.0060.3950.1350.481MDA (nmol/mg prot)30 d0.6370.8510.7520.6340.0800.1880.7590.04660 d1.961a1.971a0.907b0.659c0.043 < 0.001 < 0.0010.005SOD (U/mg prot)30 d3.0062.7032.4332.2260.2910.2740.0530.87060 d4.8455.7286.6136.2910.9950.6160.2490.5491) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. T-AOC, total antioxidant capacity. MDA, Malondialdehyde. SOD, superoxide dismutase.2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Effects of dietary selenium yeast supplementation at different concentrations on egg yolk antioxidant parameters. 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. T-AOC, total antioxidant capacity. MDA, Malondialdehyde. SOD, superoxide dismutase. 2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Immunological profiling Dietary SY supplementation selectively modulated plasma immune parameters with distinct dose–response patterns (Table 7): Plasma immunoglobulin M (IgM, a key antibody mediating primary humoral immune responses) levels exhibited significant linear and quadratic decreases (ANOVA P < 0.05; linear/quadratic P < 0.05 for both), with the 0.9SY treatment showing significantly lower levels than the control; plasma immunoglobulin G (IgG, a critical antibody involved in secondary immune responses) levels tended to increase linearly (ANOVA 0.05 < P < 0.10; linear P < 0.05), though no significant intergroup differences were observed; plasma immunoglobulin A (IgA, responsible for mucosal immunity) levels remained unaffected (ANOVA P > 0.05; no dose–response trends); plasma interleukin-6 (IL-6, a pivotal pro-inflammatory cytokine) levels decreased linearly with increasing SY dose (ANOVA P < 0.05; linear P < 0.05), with the 0.9SY treatment showing significantly lower levels than the control; plasma tumour necrosis factor-alpha (TNF-α, another key pro-inflammatory mediator) levels showed significant intergroup differences (ANOVA P < 0.05) but no dose–response trends (linear/quadratic P > 0.05), specifically, the 0.3SY treatment exhibited transiently elevated levels compared to the 0.6SY treatment, while no significant differences were observed between the 0.6SY, 0.9SY, and 0SY treatment groups. These findings indicate dietary SY exerts targeted effects on laying hen immune function: alleviating inflammatory stress (via IL-6 reduction), modulating humoral immune subsets (decreased IgM, tendency of increased IgG), and preserving mucosal immunity (stable IgA) without inducing global immunosuppression. Table 7Effects of dietary selenium yeast supplementation at different concentrations on plasma immune factor levels.Immune Factor0.0SY1)0.3SY0.6SY0.9SYSEMP value 2)ALQIgA (ug/mL)8.0818.5078.5658.6200.6990.9450.5980.793IgG (ug/mL)236.773386.062387.386383.38040.170.0720.0400.093IgM (ug/mL)51.769 a36.049 b21.26 c16.659 c2.077< 0.001< 0.0010.012TNF-α (pg/mL)16.174 ab22.368 a7.916 b10.433 ab4.242< 0.0010.1110.669IL-6 (pg/mL)17.735 a13.871 ab5.758 ab3.644 b3.896< 0.0010.0070.8241) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), and 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment.2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Effects of dietary selenium yeast supplementation at different concentrations on plasma immune factor levels. 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), and 0.9 mg (0.9SY) of SY per kilogram of diet. SEM: standard error of the mean, SEMs are based on the means of (n = 3) independent replicates per treatment. 2) A: ANOVA, the results of one-way ANOVA; L: linear, the results of linear regression analysis; Q: quadratic, the results of quadratic regression analysis. Discussion Effect of selenium yeast on the performance and egg quality of laying hens Laying performance is regulated by multiple interactive factors, including rearing environment, diet composition, and physiological homeostasis such as body weight stability during the peak laying period5,15. In the present study, laying hen body weights were well-controlled with minimal fluctuations, and dietary SY supplementation (0.3–0.9 mg/kg Se) had no significant impacts on core production metrics (average daily feed intake, egg weight, feed-to-egg ratio, laying rate, weight gain). This observation reflects the targeted role of organic Se in poultry nutrition, where modulation of functional traits such as antioxidant capacity and Se enrichment rather than direct growth promotion is typical16,17, and does not indicate insufficient supplementation levels. Mechanistically, the lack of performance interference aligns with the alignment of SY with the established dietary Se safety threshold for laying hens (≤ 1.0 mg/kg)18. Se acts as an essential cofactor for selenoproteins such as GSH-Px, which maintain basal metabolic and redox homeostasis11,12, thereby avoiding disruption of nutrient utilisation or production signalling pathways. Egg quality, a composite trait critical for commercial value, exhibited distinct dose- and time-dependent improvements with SY supplementation: eggshell thickness increased linearly at 60 days but remained unchanged at 30 days; albumen height and Haugh units (freshness markers) rose linearly at 30 days, with Haugh units showing a quadratic tendency towards elevation at 60 days; eggshell strength, shape index, and yolk colour showed no consistent treatment effects. These improvements are driven by two complementary mechanisms specific to the data of the present study: the antioxidant properties of Se scavenge reactive oxygen species (ROS) to prevent oxidation and denaturation of albumen proteins (ovalbumin)19, while cumulative Se exposure modulates the synthesis of eggshell matrix proteins (osteopontin)20, thereby explaining the delayed enhancement of shell thickness at 60 days. Supported by poultry-specific studies, including Invernizzi et al.21 reported improved egg quality with 0.4 mg/kg SY, and Muhammad et al.13 observed similar benefits with 0.6 mg/kg SY in laying hens, the current data uniquely demonstrate a time-dependent pattern not explicitly addressed in previous work. Discrepancies with Meng et al.22, who reported no SY effects on egg quality after 21–56 days, may stem from differences in SY dosage, basal diet Se content, or hen physiological status—underscoring the importance of context-specific evaluation. Among the tested doses, the 0.9 mg/kg treatment exhibited the most favourable egg quality outcomes, but this does not imply universal optimality across all production systems or laying phases. Effect of selenium yeast on egg and plasma selenium levels The present study demonstrates that SY supplementation within the tested range (0.3–0.9 mg/kg Se) induces a dose-dependent linear increase in egg and plasma selenium levels, with egg Se content reaching values that meet national standards for selenium-enriched eggs while remaining within safety thresholds for laying hens. Egg Se deposition increased proportionally with dietary Se concentration; specifically, egg Se content ranged from 0.32 mg/kg (0.3SY treatment) to 0.977 mg/kg (0.9SY treatment)—all SY-supplemented groups satisfying the Chinese national standard for selenium-enriched eggs (GH/T1135-2017; ≥ 0.15 mg/kg). This linear deposition pattern originates from the superior bioavailability of organic SY, bound to amino acids such as methionine, which is efficiently absorbed via intestinal amino acid transporters and transported to eggs via plasma lipoproteins, for example, Very Low Density Lipoprotein (VLDL)23,24, a mechanism supported by poultry-specific studies linking organic Se to targeted tissue deposition in laying hens23,25. The 0.9 mg/kg dose yielded the highest Se enrichment among the tested doses without exceeding the dietary Se toxicity threshold for laying hens (≤ 1.0 mg/kg)—a standard established by the National Research Council (NRC, 1994)18, a widely recognised authority in poultry nutrition. Doses exceeding this threshold are liable to induce oxidative stress, hepatic dysfunction, and reduced egg production26–28, but data from the present study confirm the absence of such toxicological signals: stable production performance, normal hepatic/plasma MDA levels (a marker of oxidative damage), and no abnormalities in immune or antioxidant indices. Additionally, a single egg from this group is adequate to meet the daily Se requirement (55–200 µg/day) for adults29,30, highlighting practical potential for functional egg production in commercial settings under the present experimental conditions. Discrepancies in deposition efficiency with previous studies31,32 may be attributed to differences in basal diet Se content or hen breed, underscoring the need for context-specific dosage evaluation. Taken together, these findings confirm that SY is an effective and safe supplement for short-term selenium-enriched egg production, with its dose-dependent deposition pattern reflecting the unique metabolic advantages of organic Se in peak-phase laying hens. Effect of selenium yeast on the antioxidant capacity of laying hens The present study reveals that SY supplementation (0.3–0.9 mg/kg Se) enhances the antioxidant capacity of laying hens in a tissue-specific and time-dependent manner, with the 0.9 mg/kg dose exerting the most robust effects without oxidative stress or toxicity under the experimental conditions. Specifically, hepatic and plasma SOD and GSH-Px activities increased linearly and/or quadratically with SY dose (accompanied by stable MDA levels), while yolk MDA decreased at 60 days (no consistent effects on yolk total antioxidant capacity or SOD). These outcomes align with the role of selenium as a selenoprotein cofactor8,11,19 – supporting GSH-Px-mediated hydroperoxide reduction and SOD activation to scavenge reactive oxygen species–with tissue differences reflecting metabolism rates: rapid selenoprotein synthesis in liver and plasma compared with cumulative selenium deposition in yolk24,27. Contrasting reports of excessive Se-induced adverse effects26–28 stem from doses exceeding the established dietary Se safety threshold (≤ 1.0 mg/kg)18, whereas the 0.9 mg/kg dose explains the absence of oxidative stress or toxicity observed herein. Consistent with poultry-specific studies25,26, moderate SY modulates antioxidant capacity via targeted selenoprotein activation, though long-term safety or universal optimality is not implied. Taken together, SY is a safe, effective short-term antioxidant supplement for laying hens, with the 0.9 mg/kg dose balancing efficacy and safety, and context-specific dosage refinement recommended based on diet, hen age, and stress levels. Effect of selenium yeast on plasma immunological indices in laying hens Immunoglobulins (IgM, IgA, IgG) and pro-inflammatory cytokines (IL-6, TNF-α) are core regulators of humoral immunity and inflammatory homeostasis, with Se widely recognised for its role in the beneficial modulation of immune homeostasis in poultry via targeting selenoprotein synthesis and inflammatory signalling pathways11,25. As a pivotal pro-inflammatory cytokine, IL-6 exhibited a dose-dependent linear reduction in the present study, suggesting a beneficial outcome that potentially reflects SY-mediated alleviation of inflammatory stress. This observation aligns with Hariharan & Dharmaraj11, who highlighted the role of Se in regulating inflammatory pathways through selenoprotein modulation, which is consistent with the inhibition of pro-inflammatory cytokine production reported in poultry-specific studies. Furthermore, the absence of adverse production performance effects in the group receiving the highest SY dose (0.9 mg/kg) indicates this response is likely a physiological adaptation rather than a pathological change. Regarding plasma IgM, a significant linear and quadratic reduction was observed; however, this pattern does not necessarily indicate immunosuppression. As the primary antibody mediating early humoral immune responses, IgM reduction may instead reflect Se-mediated fine-tuning of initial immune activation, an interpretation supported by three complementary lines of evidence: (i) plasma IgA levels, a critical marker of mucosal immunity and the first line of defence against pathogens, remained stable, indicating no overt compromise in barrier immune function; (ii) plasma IgG, responsible for secondary immune responses and long-term pathogen clearance, showed a tendency towards linear elevation, suggesting potential enhancement of adaptive immune memory; (iii) Sun et al.25 reported analogous findings in laying hens, where dietary Se supplementation improved immune function without impairing overall competence, attributing this effect to Se-mediated modulation of immune cell activation. This mechanism aligns with the dose-dependent trends observed herein, thereby reducing the likelihood of natural variation as the primary driver. The present study had inherent limitations, including a relatively small number of replicates per treatment, a 60-day trial duration, and a limited number of egg samples for biochemical analysis, which should be considered when interpreting the findings. Importantly, the upper SY dose (0.9 mg/kg) was within the established dietary Se safety threshold (≤ 1.0 mg/kg)18, minimising potential confounding effects of Se toxicity on immune parameters. Collectively, these data and supporting literature suggest that, under the conditions of the present study, SY may exert beneficial modulation of immune homeostasis in laying hens by selectively alleviating excessive inflammatory stress via IL-6 reduction, fine-tuning humoral immune subset activation (reduced early-stage IgM, tendency towards elevated IgG), and preserving mucosal immunity (stable IgA)—all of which reflect a potentially balanced immune adaptation rather than global immunosuppression. Further long-term trials with larger sample sizes, additional immune endpoints such as pathogen challenge tests, and diverse production systems are warranted to confirm the optimal SY dose for immune function and validate these findings more broadly. Study limitations and future directions The present study has inherent limitations that should be acknowledged. First, the 60-day feeding trial only covers the peak laying phase, failing to capture long-term effects such as cumulative selenium (Se) deposition in non-target tissues (such as the kidney and muscle), sustained laying performance, and adaptive responses to prolonged selenium yeast (SY) supplementation. While Se content in eggs and liver at the end of the trial was within the safe threshold, the dynamics of long-term accumulation remain unclear. Second, the conclusion that “0.9 mg/kg SY is the most effective dose” is based on short-term data, lacking long-term validation for sustainability. Future research will address these gaps by: (i) extending the trial to 120–180 days to monitor tissue Se deposition, long-term performance stability, and oxidative stress markers; (ii) supplementing dose–response modelling with pharmacokinetic analysis to determine the optimal sustainable dose; (iii) exploring mechanistic pathways including selenoprotein gene expression and B cell activation to validate potential immune modulation effects. Conclusion Within the framework of this 60-day trial, dietary SY supplementation (0.3–0.9 mg/kg Se) holds promise as a safe and biologically functional feed additive for laying hens, with no adverse impacts on core production performance and targeted amelioration of key functional traits. Concretely, SY mediated dose-dependent improvements in egg quality with temporal specificity, facilitated Se biofortification in eggs and plasma in a dose-responsive manner (all SY-supplemented groups complying with the national selenium-enriched egg standard, GH/T1135-2017), and enhanced tissue-specific antioxidant defence—characterised by elevated SOD and GSH-Px activities, increased plasma T-AOC, and reduced yolk MDA concentrations at trial termination. Furthermore, SY exerted selective immunomodulatory effects by downregulating the pro-inflammatory cytokine IL-6, fine-tuning humoral immune responses (reduced IgM, with a linear trend toward elevated IgG), and preserving mucosal immune integrity (stable IgA), without inducing global immunosuppression. Notably, the 0.9 mg/kg Se dose—exhibiting the most pronounced efficacy across all measured endpoints—remained within the dietary Se safety threshold (≤ 1.0 mg/kg) established by the NRC (1994), with no overt toxicological manifestations observed. Collectively, these findings indicate that 0.9 mg/kg dietary SY achieves a favourable balance between Se biofortification, enhanced egg quality, improved antioxidant capacity, and modulated immune homeostasis under the current experimental conditions. This work provides valuable insights for the application of SY in commercial selenium-enriched egg production and the sustainable improvement of laying hen health in analogous production systems, with long-term trials warranted to verify the persistence of these effects and refine dosage regimens for diverse rearing environments. Materials and methods Ethics approval and consent to participate This experiment was approved by the Animal Welfare Committee of Guizhou University (Guiyang, China), No. EAE-GZU-2020-E023. The experiment was carried out at the Yinzhan Agri-Cooperative, Kaiyang County, Guizhou Province, China (26° 56′ 30.8″ N, 107° 01′ 19.2 E) in accordance with guidelines and regulations, and the animal experiments complied with the ARRIVE guidelines. Experimental design and animal management A total of 108 healthy Hy-Line Brown laying hens (162 days old, weighing 1.61 ± 0.05 kg) were randomly divided into 4 treatment groups, with 3 replicates of nine hens per treatment (9 hens per replicate). The laying hens were given a ten-day prefeeding period to acclimate to the experimental diet before the 60-day feeding trial. The basal diet was formulated without additional selenium via the vitamin-mineral premix. A total of four treatment groups were established: the control group (0SY) was fed the basal diet alone, while the experimental groups (designated as 0.3SY, 0.6SY, and 0.9SY) received the same basal diet supplemented with 0.3, 0.6, or 0.9 mg/kg selenium yeast (SY, 2400 mg/kg, ANGEL YEAST Co., Ltd, China). which was stored in airtight aluminum foil bags at 4–8 °C in a dark, dry environment to prevent oxidation and maintain stability and used within the shelf life specified by the product label to ensure bioactivity. All diets were formulated based on Tables of Feed Composition and Nutritive Values in China (31st Edition, 2020) and the nutritional requirements for laying hens according to the National Research Council (NRC, 1994)18, with detailed composition and nutrient concentrations of the basal diet are presented in Table 8, and the experimental diets were pelleted with a particle size of 3–4 mm to ensure uniform nutrient distribution and improve feed intake. Background Se in the basal diet was determined as 0.14 mg/kg from the control diet—actual added Se (SY-derived) was calculated as verified total Se minus 0.14 mg/kg, yielding 0.28, 0.59, and 0.87 mg/kg for 0.3SY, 0.6SY, and 0.9SY, respectively. During the trial, the hens were raised in a semi-open forest farming system, fed twice daily at 08:00 and 15:00 h, with ad libitum access to water. The stocking density during free-range was 2 birds/m2. In the housing system, hens were housed in cages (100 × 75 × 50 cm, L × W × H) with 2 hens per cage. Throughout the experiment, environmental conditions were maintained at constant levels: temperature 20–25 °C, relative humidity 60–70%, and a 16L:8D photoperiod. Table 8Ingredients and nutrient levels of basal diet (air dry basis, %).Items1)0SY1)0.3SY0.6SY0.9SYIngredients––––Corn52.3052.3052.3052.30Wheat10.0010.0010.0010.00Soybean meal19.8019.8019.8019.80Fermentation material3.003.003.003.00Limestone9.009.009.009.00CaHPO41.001.001.001.00DDGS3.003.003.003.00Premix2)1.901.901.901.90Total100.00100.00100.00100.00Dietary Se content/(mg/kg)3)0.140.521.041.22Nutrient––––ME/(MJ/kg)10.9010.9010.9010.90CP16.0016.0016.0016.00Ca3.703.703.703.70Effective phosphorus0.280.280.280.28Total phosphorus0.520.520.520.52Lysine0.810.810.810.81Methionine0.340.340.340.34Cystine0.260.260.260.26Fat2.802.802.802.801) In the table, values with different superscripts indicate a significant difference (P < 0.05). ADFI, average daily feed intake. AEW, average egg weight. F/E, feed/egg ratio. SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. DDGS, Distillers Dried Grains with Solubles. ME, metabolizable energy. CP, crude protein. Ca, Calcium.2)The premix provides the following per kilogram diet: vitamin A, 12,500 IU; vitamin D3, 425 KIU; vitamin E, 150 mg; vitamin K3, 3 mg; vitamin B1, 1 mg; vitamin B2, 8.6 mg; vitamin B6, 8 mg; vitamin B12, 5 mg; niacin, 33 mg; folic acid, 6 mg; D-pantothenic acid, 50 mg; biotin, 2 mg; Cu, 8 mg; Fe, 60 mg; Zn, 66 mg; Mn, 65 mg; I, 1 mg.3) The dietary Se content and nutrient levels were measured, and this study focused on Se content. Listed Se = verified total Se (mg/kg, post-feeding analysis of experimental diets). Background Se = 0.14 mg/kg (quantified from control diet). Actual added Se (mg/kg) = verified total Se − background Se. Ingredients and nutrient levels of basal diet (air dry basis, %). 1) In the table, values with different superscripts indicate a significant difference (P < 0.05). ADFI, average daily feed intake. AEW, average egg weight. F/E, feed/egg ratio. SY was added to a basic diet (without Se in the premix). The control treatment (0SY) group received 0 mg of SY, whereas the treatment groups received 0.3 mg (0.3SY), 0.6 mg (0.6SY), or 0.9 mg (0.9SY) of SY per kilogram of diet. DDGS, Distillers Dried Grains with Solubles. ME, metabolizable energy. CP, crude protein. Ca, Calcium. 2)The premix provides the following per kilogram diet: vitamin A, 12,500 IU; vitamin D3, 425 KIU; vitamin E, 150 mg; vitamin K3, 3 mg; vitamin B1, 1 mg; vitamin B2, 8.6 mg; vitamin B6, 8 mg; vitamin B12, 5 mg; niacin, 33 mg; folic acid, 6 mg; D-pantothenic acid, 50 mg; biotin, 2 mg; Cu, 8 mg; Fe, 60 mg; Zn, 66 mg; Mn, 65 mg; I, 1 mg. 3) The dietary Se content and nutrient levels were measured, and this study focused on Se content. Listed Se = verified total Se (mg/kg, post-feeding analysis of experimental diets). Background Se = 0.14 mg/kg (quantified from control diet). Actual added Se (mg/kg) = verified total Se − background Se. Sample collection and analysis Growth and production performance parameters Individual hen weights were recorded on Days 0 and 60. Daily feed intake, total egg production, and egg weights were measured per replicate. The calculations included: Average daily feed intake (ADFI, g): Feed consumption of laying hens/(feeding period × number of laying hens). Average egg weight (AEW, g): Total egg weight laid/number of eggs laid. Egg production rate (%): Total number of eggs laid/number of laying hens × 100% Feed-to-egg ratio (F/E): Feed consumption/weight of eggs laid. Laying weight gain: Average weight of laying hens on Day 60/average weight of laying hens on Day 0. Egg quality assessment On Days 30 and 60, four eggs per replicate were randomly selected for egg quality analysis. The egg shape index was determined using Vernier callipers (MNT-150, Germany) according to Duman et al.33 method. Eggshell strength, albumen height, yolk colour, and Haugh units were measured with an Egg Multi Tester EMT-7300 (Robotmation Co., Japan). Eggshell thickness was quantified post membrane removal using an ESTG-1 gauge (Orka Food Technology, Israel). Egg Yolk, plasma and liver antioxidant parameter analyses Antioxidant capacity was assessed in egg yolk, plasma, and liver samples. On the 30th and 60th days of the experiment, three eggs were randomly selected from each replicate. Egg yolks were separated using a plastic egg separator and transferred into centrifuge tubes via a 1000 µL pipette tip before being stored at − 80 °C. The frozen yolks were vacuum freeze-dried for 3–4 days, and the resulting freeze-dried yolk powder was transferred into 5 mL cryovials and stored at −80 °C until analysis. Before analysis, the freeze-dried yolk powder from the three eggs within each replicate was pooled and homogenised in saline at a ratio of 0.5 g powder to 4.5 mL saline (1:9, w/v). On the final day of the experiment, one hen per replicate was randomly selected after a 12-h fast. From each hen, 5 mL of blood was collected from the wing vein and centrifuged at 3000 × g for 15 min to obtain plasma, which was aliquoted into three 2 mL centrifuge tubes and stored at −20 °C. Concurrently, three portions of liver tissue were collected from each hen as sub-samples and stored at − 80 °C. For pretreatment, each liver tissue portion was accurately weighed and homogenised individually in a four-fold volume of saline relative to tissue weight (v/w, 4 mL saline per 1 g liver tissue) using an ice-water bath to ensure complete cell disruption. The homogenates were centrifuged at 12,000 × g for 5 min at 4 °C, and the supernatants were collected. For all samples (yolk homogenates, plasma aliquots, liver supernatants), antioxidant indices were analysed in technical duplicates, with replicate-specific data points generated as follows: the average of technical duplicates for the pooled yolk homogenate (egg yolk), the average of technical duplicates across the three plasma aliquots (plasma), and the average of technical duplicates per liver sub-sample (subsequently averaged across the three sub-samples for liver). Antioxidant capacity was evaluated using commercial assay kits from Nanjing Jiancheng Bioengineering Institute (Nanjing, China), including SOD (hydroxylamine method, cat. no. A001-2–2), MDA (thiobarbituric acid method, cat. no. A003-1–2), GSH-Px (colorimetric method, cat. no. A005-1–2), and T-AOC (ferric ion reducing antioxidant power [FRAP] method, cat. no. A015-3–1). Plasma levels of immune factors The plasma levels of IgA (RX600493CH), IgM (RX600488CH), IgG (RX600491CH), TNF-α (RX600568CH), and IL-6 (RX600551CH) were measured using double-antibody sandwich ELISA kits (Quanzhou Ruixin Biological, China). The assays were conducted following the manufacturer’s instructions, and the absorbance was measured using a microplate reader (BioTek, USA). Standard curve equations were generated using four-parameter logistic curve fitting (4-PL), and sample concentrations were calculated based on optical density (OD) values. Egg and plasma selenium levels On Day 60, three eggs per replicate were randomly selected for Se content analysis using the hydride atomic fluorescence spectrometry method described by Li et al.32, and this method was also used for post-feeding verification of total Se in experimental diets. Briefly, samples were digested using an acidic heating process, converting hexavalent Se () to tetravalent Se () in a 6 mol/L hydrochloric acid medium. Subsequently, sodium borohydride or potassium borohydride was used to reduce to hydrogen selenide (H₂Se). A stream of argon gas transported H₂Se into the atomiser, where Se atoms were excited by irradiation from a Se hollow cathode lamp, emitting fluorescence at characteristic wavelengths. The fluorescence intensity was proportional to the Se concentration, which was quantified using a standard curve. Statistical analyses The replicate (i.e., the group of nine hens) was considered the experimental unit for all analyses, as dietary treatments were applied at the group level. Accordingly, data for each measured variable were averaged by replicate, and these replicate means (n = 3 per treatment) were used for all subsequent analyses. Statistical analyses were performed on these means using the General Linear Model (GLM) procedure in SPSS version 25.0. Homogeneity of variance was tested via Levene’s test, and normality was assessed with the Shapiro–Wilk test. Tukey’s test was applied for multiple comparisons when the assumption of equal variance was met; otherwise, Tamhane’s T2 test was used for pairwise comparisons. Orthogonal polynomial contrasts were applied to assess the linear and quadratic effects of different SY levels. The results are expressed as the means ± standard errors of the mean (SEM), with differences considered significant at P < 0.05, while P values between 0.05 and 0.10 indicated no significant group differences but a marginal trend. Acknowledgements This study was completed at the Key Laboratory of Plateau Mountain Animal Genetics, Breeding and Reproduction of Ministry of Education (Guizhou University, Guiyang, China). Author contributions Tingting Wang: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Software, Validation, Visualisation, Writing—original draft and review & editing. Shengchang Chen: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Funding acquisition, Project administration, Resources, Writing—review & editing. Shengyong Lu: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Project administration, Resources, Writing—review & editing. Haixia Li: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Software, Validation, Visualisation, Writing—original draft & editing. Mengmeng Ni: Conceptualisation, Writing—review & editing. Jun Hao: Conceptualisation, Investigation, Methodology, Writing—review & editing. Wei Cheng: Conceptualisation, Investigation, Writing—review & editing. Jingshang Li: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Software, Validation, Visualisation. Yunce Cai: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Software, Validation, Visualisation. Jiaxiu An: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Software, Validation, Visualisation. Long Qin: Conceptualisation, Investigation, Methodology, Data curation, Formal analysis, Software, Validation, Visualisation.All authors read and approved the final manuscript. Funding The authors are grateful for the support of this experiment provided by the project “Integration and Demonstration of Key Technologies of ecological selenium-rich laying hens in Forest Culture (Guizhou Joint support [2020]1Y046)”. Data availability The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request. Declarations Competing interests The authors declare no competing interests. Ethical approval and consent to participate This experiment was approved by the Animal Welfare Committee of Guizhou University (Guiyang, China), No. EAE-GZU-2020-E023. The experiment was carried out at the Yinzhan Agri-Cooperative, Kaiyang County, Guizhou Province, China (26°56′30.8″ N, 107°01′19.2 E) in accordance with guidelines and regulations, and the animal experiments complied with the ARRIVE guidelines. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Shengchang Chen, Email: csc0427@126.com. Shengyong Lu, Email: 3239245713@qq.com. References Associated Data Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.